tiprankstipranks
C4 Therapeutics announces first patient dosed in CFT8919 clinical trial
PremiumThe FlyC4 Therapeutics announces first patient dosed in CFT8919 clinical trial
1M ago
C4 Therapeutics Advances in Protein Degradation Therapy
Premium
Company Announcements
C4 Therapeutics Advances in Protein Degradation Therapy
2M ago
C4 Therapeutics files $400M mixed securities shelf
Premium
The Fly
C4 Therapeutics files $400M mixed securities shelf
2M ago
C4 Therapeutics announces next steps for CFT1946
PremiumThe FlyC4 Therapeutics announces next steps for CFT1946
3M ago
C4 Therapeutics presents monotherapy data from CFT1946 Phase 1 trial
Premium
The Fly
C4 Therapeutics presents monotherapy data from CFT1946 Phase 1 trial
3M ago
C4 Therapeutics announces delivery of second development candidate to Biogen
Premium
The Fly
C4 Therapeutics announces delivery of second development candidate to Biogen
3M ago
C4 Therapeutics Appoints Mr. Cooper to Board
PremiumCompany AnnouncementsC4 Therapeutics Appoints Mr. Cooper to Board
6M ago
C4 Therapeutics appoints Cooper as Chairman of Board of Directors
Premium
The Fly
C4 Therapeutics appoints Cooper as Chairman of Board of Directors
6M ago
C4 Therapeutics participates in a conference call with JPMorgan
Premium
The Fly
C4 Therapeutics participates in a conference call with JPMorgan
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100